GB1115037A - Improvements in or relating to indolylethylamines - Google Patents

Improvements in or relating to indolylethylamines

Info

Publication number
GB1115037A
GB1115037A GB11993/65A GB1199365A GB1115037A GB 1115037 A GB1115037 A GB 1115037A GB 11993/65 A GB11993/65 A GB 11993/65A GB 1199365 A GB1199365 A GB 1199365A GB 1115037 A GB1115037 A GB 1115037A
Authority
GB
United Kingdom
Prior art keywords
formula
hydrogen atom
group
compounds
converted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB11993/65A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Koninklijke Philips NV
Original Assignee
Philips Gloeilampenfabrieken NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Philips Gloeilampenfabrieken NV filed Critical Philips Gloeilampenfabrieken NV
Publication of GB1115037A publication Critical patent/GB1115037A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C07D209/16Tryptamines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Compounds of the general Formula I <FORM:1115037/C2/1> wherein R1 and R2 each represents a hydroxy or alkoxy group, n1 = 1 or 2, n2 = 0 or 1, R3 represents a hydrogen atom or C1- 4 alkyl group and R4 represents a hydrogen atom, a C1- 4 alkyl group or a group of the Formula Ia <FORM:1115037/C2/2> and their acid addition salts are prepared by standard methods, such as reacting a compound of the Formula V <FORM:1115037/C2/3> with a compound of the Formula VI <FORM:1115037/C2/4> in which formulae R11 and R21 have the same meanings as R1 and R2 in Formula I of the desired product or represent one or more etherified or esterified hydroxy groups which, after the reaction, is or are converted into a free hydroxy group or groups by hydrolysis or hydrogenolysis, R41 has the same meaning as R4 in Formula I or represents an aralkyl group which, after the reaction, is replaced by a hydrogen atom by catalytic reduction, and X represents a halogen atom, in which case n3 = 1, or a double-bonded oxygen atom, in which case n3 = 0 and R41 is a hydrogen atom, the intermediately formed Schiff base being converted into the amine of Formula I by reduction, optionally followed by salt formation. The preparation of o-(2-bromoethoxy)-anisole is described. The compounds of the invention have sedative, anticonvulsant, analgesic and hypotensive activity and some of then have adrenolytic activity. They may be administered in the form of pharmaceutical preparations containing them together with a carrier. Reference has been directed by the Comptroller to Specification 942,548.
GB11993/65A 1964-03-24 1965-03-24 Improvements in or relating to indolylethylamines Expired GB1115037A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL6403114A NL6403114A (en) 1964-03-24 1964-03-24

Publications (1)

Publication Number Publication Date
GB1115037A true GB1115037A (en) 1968-05-22

Family

ID=19789634

Family Applications (1)

Application Number Title Priority Date Filing Date
GB11993/65A Expired GB1115037A (en) 1964-03-24 1965-03-24 Improvements in or relating to indolylethylamines

Country Status (10)

Country Link
AT (2) AT253498B (en)
BE (1) BE661486A (en)
BR (1) BR6568028D0 (en)
CH (1) CH475239A (en)
DE (1) DE1620069A1 (en)
ES (1) ES310830A1 (en)
FR (1) FR4516M (en)
GB (1) GB1115037A (en)
NL (1) NL6403114A (en)
SE (1) SE303504B (en)

Also Published As

Publication number Publication date
ES310830A1 (en) 1965-12-01
DE1620069A1 (en) 1970-03-12
SE303504B (en) 1968-09-02
AT254860B (en) 1967-06-12
NL6403114A (en) 1965-09-27
FR4516M (en) 1966-10-17
BE661486A (en) 1965-09-22
CH475239A (en) 1969-07-15
AT253498B (en) 1967-04-10
BR6568028D0 (en) 1973-12-26

Similar Documents

Publication Publication Date Title
ES8207156A1 (en) Pyrimidones, their preparation and medicines containing them.
GB1106040A (en) Novel benzdiaz[1,4]epine derivatives and a process for the manufacture thereof
ES479820A1 (en) Isoquinoline derivatives, process for their preparation and pharmaceutical compositions containing them.
ES289813A1 (en) 5-phenyl-3h-1,4-benzodiazepine-2(ih)-thione and derivatives thereof
GB1188154A (en) New Pyridine Derivatives and process for their preparation
GB1104145A (en) Pyrazolo-pyridine derivatives
GB1082163A (en) Novel quinazoline derivatives and a process for the manufacture thereof
GB1115037A (en) Improvements in or relating to indolylethylamines
ES8402839A1 (en) Polycyclic polyazaheterocycles, process for their preparation and pharmaceutical preparations containing them.
ES295039A1 (en) 10-(basic substituted)-dibenz[b, f][1, 4] oxazepinones
ES424309A1 (en) N-(heteroaryl-methyl)-7{60 -acyl-6,14-(endoetheno or endoethano)-tetrahydro-nororipavines or-thebaines and salts thereof
GB1324579A (en) N-substituted 3-aminoalkoxy-6-hydrazinopyridazines having antihypertensive activity and their preparation
GB1144516A (en) Novel oximes and a process for the manufacture and conversion thereof
ES397453A1 (en) Imidazoline derivatives of benzonorbornane and tetrahydronaphthalene compounds
GB1254270A (en) Benzoxazepine derivatives
ES426771A1 (en) Aminopropanol substituted isochromanones and phthalides
ES348550A1 (en) Substituted-2,3-dichloroquinoxalines and processes for preparing same
ES483391A1 (en) Pyrano-heterocycles, process for their preparation and pharmaceutical compositions containing them.
GB1023203A (en) Propylamine derivatives
GB1105007A (en) Nitrone derivatives and processes for preparation thereof
ES378361A1 (en) Nitroimidazolyl nitrones
ES344072A1 (en) Basically substituted 2-imidazolidone derivatives and their production
GB1478988A (en) Digitoxin orthoformates
GB989191A (en) Benzimidazole derivatives and process for making them
GB1022957A (en) New amidines and process for preparing them